Investing.com -- The U.S. Food and Drug Administration has approved gardenia (genipin) blue for use in various foods, marking the fourth natural color additive approved in the last two months.

Meanwhile, Bloomberg reports that the FDA may offer to fast-track drug reviews for companies that lower their U.S drug prices. Also: a billion-dollar backlog of delayed grants at HHS, and more.

FDA Commissioner Marty Makary's vision for the agency risks the best of an agency that mostly has functioned well for the ...

Through its recently unveiled Priority Voucher program, the FDA seeks to accelerate the review process for companies that ...

FDA is urging manufacturers of infant formula, baby food and children’s nutrition products to sharpen their recall ...

Market reaction to recent readouts from Compass Pathways and Beckley Psytech/atai in treatment-resistant depression speaks to ...

In a landmark move to improve transparency and modernize regulatory processes, the U.S. Food and Drug Administration (FDA) ...

The U.S. Food and Drug Administration (FDA) is calling on manufacturers and distributors of infant formula, baby foods, and other foods intended for children to strengthen and ...

Both Students for Life and Liberty Counsel have claimed that mifepristone is contaminating public water systems, as well as rivers and streams, after remnants of the medication and pregnancy tissue ...

The Food and Drug Administration (FDA) can maintain its high bar for safety and efficacy, and also cut the waste and ...

Food and Drug Administration Commissioner Marty Makary said his agency may fast-track new drugs from pharmaceutical companies that “equalize” the cost of their medicines between the US and other ...